Clinical research - Press Releases

Date	Title	Company
25-Mar-2022	Envirotainer’s Releye® RAP container already approved by 10 airlines	Envirotainer
24-Mar-2022	Citizens can generate novel and high-impact research questions for science	BlueSky Education
23-Mar-2022	Moberg Pharma announces regulatory submission to FDA for North American phase 3 study	Moberg Pharma
22-Mar-2022	Innovative collaboration to offer heart rhythm checks throughout the North West to detect Atrial Fibrillation via Community Pharmacies	Daiichi Sankyo and O’Brien’s Pharmacies Group
22-Mar-2022	Zygel’s anticipated impact on underserved fragile X syndrome market sees sales estimates of $18.1 million, says GlobalData	Zynerba Pharmaceuticals
22-Mar-2022	Sajid Javid is sticking his head in the sand, expert warns, as long Covid cases mount and immunity falls	London Medical Laboratory
22-Mar-2022	CELL AND GENE THERAPY CATAPULT LAUNCHES 2021 CLINICAL TRIALS DATABASE REPORT	The Cell and Gene Therapy Catapult (CGT Catapult)
22-Mar-2022	Biocomposites signs agreement with Zimmer Biomet to distribute new genex Bone Graft Substitute	Biocomposites
22-Mar-2022	Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry	Envision Pharma Group
22-Mar-2022	SmiLe Inject invests 2 MSEK in eHealth company developing a voice robot for the elderly	SmiLe
22-Mar-2022	bioLytical Laboratories Inc. Receives its CE Mark for the iStatis COVID-19 Antigen Home Test	bioLytical Laboratories Inc
17-Mar-2022	Sanofi provides update on Phase 2 study evaluating amcenestrant in ER+/HER2- advanced or metastatic breast cancer	Sanofi
16-Mar-2022	Omnix Medical Advances Novel Anti-Infective Program into Clinical Development	Omnix Medical
15-Mar-2022	Sanofi provides update on Phase 2 study evaluating amcenestrant in ER+/HER2- advanced or metastatic breast cancer	Sanofi
11-Mar-2022	Emmes Acquires Casimir, Its Fourth Major Acquisition	Emmes
11-Mar-2022	How Will High Prevalence of CVD Boost Robotic Catheter Systems Market Growth?	P&S Intelligence
10-Mar-2022	Tiziana Announces Positive Clinical Data from A Secondary Progressive Multiple Sclerosis Patient Treated for Six Months with Intranasally Administered Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody	Tiziana Life Sciences
10-Mar-2022	Versameb CEO Klaas Zuideveld to Present at the RNA Leaders World Congress	Versameb AG
08-Mar-2022	Rapid Microbial Methods, Contamination Control, Sterility Assurance and Environmental Monitoring to be covered at Microbiology East Coast Conference in Boston	SMi Group
07-Mar-2022	UK Regulator Cites CluePoints’ Solutions in Updated Guidance	CluePoints